These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26758964)

  • 1. Clinical and Genetic Characteristics, Management and Long-Term Follow-Up of Turkish Patients with Congenital Hyperinsulinism.
    Güven A; Cebeci AN; Ellard S; Flanagan SE
    J Clin Res Pediatr Endocrinol; 2016 Jun; 8(2):197-204. PubMed ID: 26758964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.
    Xu A; Cheng J; Sheng H; Wen Z; Lin Y; Zhou Z; Zeng C; Shao Y; Li C; Liu L; Li X
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):400-409. PubMed ID: 31208162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and phenotype-genotype analysis in Turkish patients with congenital hyperinsulinism; predominance of recessive KATP channel mutations.
    Demirbilek H; Arya VB; Ozbek MN; Akinci A; Dogan M; Demirel F; Houghton J; Kaba S; Guzel F; Baran RT; Unal S; Tekkes S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Jun; 170(6):885-92. PubMed ID: 24686051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
    Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
    Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histological heterogeneity of congenital hyperinsulinism due to paternally inherited heterozygous ABCC8/KCNJ11 mutations.
    Arya VB; Guemes M; Nessa A; Alam S; Shah P; Gilbert C; Senniappan S; Flanagan SE; Ellard S; Hussain K
    Eur J Endocrinol; 2014 Dec; 171(6):685-95. PubMed ID: 25201519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic characterization of congenital hyperinsulinism in Spain.
    Martínez R; Fernández-Ramos C; Vela A; Velayos T; Aguayo A; Urrutia I; Rica I; Castaño L;
    Eur J Endocrinol; 2016 Jun; 174(6):717-26. PubMed ID: 27188453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of ABCC8, KCNJ11, GLUD1, HNF4A and GCK genes in 30 Chinese patients with congenital hyperinsulinism.
    Sang Y; Xu Z; Liu M; Yan J; Wu Y; Zhu C; Ni G
    Endocr J; 2014; 61(9):901-10. PubMed ID: 25008049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.
    Banerjee I; Skae M; Flanagan SE; Rigby L; Patel L; Didi M; Blair J; Ehtisham S; Ellard S; Cosgrove KE; Dunne MJ; Clayton PE
    Eur J Endocrinol; 2011 May; 164(5):733-40. PubMed ID: 21378087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism.
    Kapoor RR; Flanagan SE; Arya VB; Shield JP; Ellard S; Hussain K
    Eur J Endocrinol; 2013 Apr; 168(4):557-64. PubMed ID: 23345197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and phenotype-genotype review of 25 Omani children with congenital hyperinsulinism in infancy. A one-decade single-center experience.
    Al-Badi MK; Al-Azkawi HS; Al-Yahyaei MS; Mula-Abed WA; Al-Senani AM
    Saudi Med J; 2019 Jul; 40(7):669-674. PubMed ID: 31287126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
    Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
    J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in ABCC8 gene in a newborn with congenital hyperinsulinism -a case report.
    Üstün NU; Dilli D; Kundak AA; Okumus N; Erdoğan D; Apaydın S
    Fetal Pediatr Pathol; 2013 Dec; 32(6):412-7. PubMed ID: 23607867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics, outcome, and predictors of neurological sequelae of persistent congenital hyperinsulinism: A single tertiary center experience.
    Laimon W; Aboelenin HM; El Tantawi NT
    Pediatr Diabetes; 2021 May; 22(3):388-399. PubMed ID: 33528087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could a combination of heterozygous ABCC8 and KCNJ11 mutations cause congenital hyperinsulinism?
    Rozenkova K; Nessa A; Obermannova B; Elblova L; Dusatkova P; Sumnik Z; Lebl J; Hussain K; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1311-1315. PubMed ID: 29127764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up and mutation analysis of 27 chinese cases of congenital hyperinsulinism.
    Su C; Gong C; Sanger P; Li W; Wu D; Gu Y; Cao B
    Horm Res Paediatr; 2014; 81(3):169-76. PubMed ID: 24434300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating Genetic Mutations in a Large Cohort of Iranian Patients with Congenital Hyperinsulinism.
    Razzaghy-Azar M; Saeedi S; Dayani SB; Enayati S; Abbasi F; Hashemian S; Eshraghi P; Karimdadi S; Tajdini P; Vakili R; Amoli MM; Yaghootkar H
    J Clin Res Pediatr Endocrinol; 2022 Mar; 14(1):87-95. PubMed ID: 34927408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the ABCC8 gene mutation and phenotype in patients with congenital hyperinsulinism in western Saudi Arabia.
    Al-Agha AE; Ahmad IA
    Saudi Med J; 2013 Oct; 34(10):1002-6. PubMed ID: 24145932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.